Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease
The anti-inflammatory drug colchicine has been shown to reduce cardiovascular events after recent myocardial infarction. Now, a trial in the New England Journal of Medicine reports that daily low-dose colchicine also significantly reduces the cardiovascular event risk among patients with chronic coronary disease.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cardiology | Cardiovascular | Colchicine | Colcrys | General Medicine | Heart | Heart Attack